The FDA extended the use of the antiviral remdesivir last week for treatment of mild to moderate coronavirus. However, it's not available yet. Now, the scramble for treatment has intensified.
LOS ANGELES -- Doctors treating COVID-19 patients are having a difficult time finding new medications designed to keep them out of hospitals.
"We have these therapies that we know are effective at keeping patients out of the hospitals, out of our ERs and out of the ICUs, and unfortunately, we are not able to find them," he said. All three companies said they've only received limited supplies and what they get is sent to stores in areas federally designated as high-risk and socially-vulnerable.
Meanwhile, CVS said,"We've started to receive our initial and limited allocated supply of Pfizer and Merck oral antiviral COVID-19 therapies as determined by the federal government, subject to each State's selection of CVS Pharmacy as a participating provider.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults
Consulte Mais informação »
Cannabis compound CBD stops coronavirus in test tube, but can it treat COVID?Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat COVID-19 warrants further investigation in rigorous clinical trials, researchers say.
Consulte Mais informação »
National Guard Sees Troops Reupping Despite COVID, Hard YearAll over the U.S., state National Guard units are seeing dramatic reenlistment rates, even as their troops juggle near constant duties with COVID-19, natural disasters and other military deployments.
Consulte Mais informação »
Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Consulte Mais informação »
Illinois schools could see fewer student quarantines from COVID-19 close contactsIllinois students who are exposed to COVID-19 but already had a confirmed case of the virus in the past three months will no longer be excluded from the classroom.
Consulte Mais informação »